Helix TCS: A Clear Market Leader in Cannabis Ancillary Services
February 11th, 2019
Exclusive, News, Top News
The legal cannabis industry (“LCI”) is projected to reach nearly $150 billion in revenue by 2025, according to Grand View Research, driven by the legalization of medical and adult-use cannabis around the world. Despite these rapid growth rates, there’s a significant shortage of support services to help cultivators, wholesalers, processors, and retailers navigate the complex regulatory environments that have been setup by government regulatory bodies.
Helix TCS Inc. (OTCQB: HLIX) aims to close the gap by offering the world’s largest cannabis-focused suite of vertically-integrated services and technologies. After a string of highly successful acquisitions, investors may want to keep an eye on the stock as revenue continues to grow and new catalysts surface over the coming year.
Growing Demand for Support Services
Support services for the cannabis industry are underdeveloped and virtually non-existent, especially those that span across unique jurisdictions. At the same time, the cannabis industry faces an enormous regulatory burden that is challenging for many businesses to handle on their own. These dynamics have created an opportunity for startups to quickly capture market share as the cannabis industry continues to grow at a breakneck pace across the United States and around the world.
Helix TCS’ Critical Infrastructure Services Platform provides a level of risk management not found anywhere else in the industry. Over the past several years, the company made several accretive acquisitions and subsequently enhanced and grew the acquired revenue streams. The roll-up business model provides investors with rapidly growing revenue and market shares within the nascent cannabis industry’s ancillary services segment.
The company has made acquisitions across the technology, compliance, and security niche segments:
- BioTrackTHC is a pioneer in seed-to-sale tracking and government compliance software with thousands of customers throughout the United States and beyond, providing both revenue and upsell opportunities for other services.
- Cannabase has created the first LCI wholesale cannabis marketplace.
- Helix Security provides 360 degree business security frameworks with a special focus on cannabis industry compliance, providing video, alarm, and access control systems, as well as recurring revenue from remote surveillance or “virtual guard” systems; a high margin service that is highly attractive to licensed operators.
- Amercanex, a recent acquisition, will provide Helix with an Electronic Communications Network that will allow it to deploy the industry’s first compliant, real-time wholesale cannabis exchange to a global marketplace. The collective dominant market share of BioTrackTHC, Cannabase, and Amercanex, will be leveraged to build out the vast client base.
The company’s strategy focuses on acquisitions to synergistically build on these offerings, including the LCI wholesale commodity exchange, a software development firm, multi-state security expansion, and international product line expansion.
Experienced Team Delivers Results
Management’s breadth and depth of industry experience translates to best-in-class performance that meets any jurisdiction’s compliance requirements through cutting-edge technology and supply chain management solutions. CEO Zachary L. Venegas and CFO Scott Ogur have worked together in frontier markets and private equity for over 15 years, with multiple international ventures and successful exits.
Over the past three years, the company has grown to service over 2,000 cannabis businesses across retail, cultivation, and manufacturing sectors. One-fifth of Colorado’s largest cannabis businesses employ Helix security, while BioTrackTHC has captured about half of the U.S. dispensary point of sale software market and clients in multiple countries. The cross-selling opportunities between these businesses could propel growth over the coming quarters.
These strongly established networks and relationships with legal cannabis businesses from all segments provide a durable competitive advantage in regulated cannabis markets. In addition, the transactional data set from BioTrackTHC is the largest in the industry, having tracked over $18 billion in legal cannabis sales, and will provide Helix with the ability to monetize that data through a variety of premium service offerings.
Helix TCS Inc. (OTCQB: HLIX) is uniquely positioned as a clear leader in the cannabis technology, compliance, and security services business. With its portfolio of acquisitions, the company is rapidly growing revenue and unlocking value through cross-selling opportunities and other synergies with one of the largest customer networks in the regulated industry. Investors may want to keep an eye on the stock given these unique dynamics, particularly given the BioTrackTHC transaction and its recent developments.
For more information, visit the company’s website at www.helixtcs.com.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.